This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wasan, K. M.
Right arrow Articles by Thies, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wasan, K. M.
Right arrow Articles by Thies, R. L.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, Sep 1997, 1871-1875, Vol 41, No. 9
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Physical characteristics and lipoprotein distribution of liposomal nystatin in human plasma

KM Wasan, M Ramaswamy, SM Cassidy, M Kazemi, FW Strobel and RL Thies
Division of Pharmaceutics and Biopharmaceutics, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada. Kwasan@unixg.ubc.ca

The physical characteristics and lipoprotein distribution of free nystatin (NYS) and liposomal NYS (L-NYS) in human plasma were investigated. To determine the percentage of NYS that was lipid associated following incubation in human plasma, C18 reverse-phase extraction columns were used. To assess plasma drug distribution, NYS and L-NYS (20 microg/ml) were incubated in human plasma for 5, 60, and 120 min at 37 degrees C. After each interval, plasma was removed and separated into its lipoprotein and lipoprotein-deficient plasma (LPDP) fractions by ultracentrifugation and assayed for NYS by high-pressure liquid chromatography. Further studies evaluated the liposome structure of L-NYS by filtering through a 0.14-microm-pore-size microfilter before and after the addition of human plasma. When reconstituted L-NYS (mean particle diameter +/- standard deviation, 321 +/- 192 nm) was applied to a C18 column, 67% +/- 4% of the initial NYS concentration was associated with the lipid. When plasma samples containing L-NYS that had been incubated for 5 to 120 min at 37 degrees C were applied to C18 columns, 66 to 76% of the NYS was lipid associated. Incubation of NYS in human plasma for 5 min at 37 degrees C resulted in 3% +/- 1% of the initial NYS concentration incubated in the low-density lipoprotein (LDL) fraction, 23% +/- 4% of that in the high-density lipoprotein (HDL) fraction, and 66% +/- 10% of that in the LPDP fraction. In contrast, the distribution of NYS following incubation of L-NYS in human plasma for 5 min was 13% +/- 2% in the LDL fraction, 44% +/- 5% in the HDL fraction, and 42% +/- 5% in the LPDP fraction. Similar results were observed following 60 and 120 min of incubation. In addition, the liposome structure of L-NYS was quickly lost when mixed with plasma. These findings suggest that rapid disruption of the L-NYS structure upon incubation in human plasma is consistent with its rapid distribution in plasma. The preferential distribution of NYS into the HDL fraction upon incubation of L-NYS may be a function of its phospholipid composition.


This article has been cited by other articles:

  • Meletiadis, J., Chanock, S., Walsh, T. J. (2006). Human Pharmacogenomic Variations and Their Implications for Antifungal Efficacy. Clin. Microbiol. Rev. 19: 763-787 [Abstract] [Full Text]  
  • Groll, A. H., Mickiene, D., Petraitis, V., Petraitiene, R., Alfaro, R. M., King, C., Piscitelli, S. C., Walsh, T. J. (2003). Comparative Drug Disposition, Urinary Pharmacokinetics, and Renal Effects of Multilamellar Liposomal Nystatin and Amphotericin B Deoxycholate in Rabbits. Antimicrob. Agents Chemother. 47: 3917-3925 [Abstract] [Full Text]  
  • Groll, A. H., Mickiene, D., Werner, K., Petraitiene, R., Petraitis, V., Calendario, M., Field-Ridley, A., Crisp, J., Piscitelli, S. C., Walsh, T. J. (2000). Compartmental Pharmacokinetics and Tissue Distribution of Multilamellar Liposomal Nystatin in Rabbits. Antimicrob. Agents Chemother. 44: 950-957 [Abstract] [Full Text]  
  • Groll, A. H., Petraitis, V., Petraitiene, R., Field-Ridley, A., Calendario, M., Bacher, J., Piscitelli, S. C., Walsh, T. J. (1999). Safety and Efficacy of Multilamellar Liposomal Nystatin against Disseminated Candidiasis in Persistently Neutropenic Rabbits. Antimicrob. Agents Chemother. 43: 2463-2467 [Abstract] [Full Text]  
  • Ramaswamy, M., Wallace, T. L., Cossum, P. A., Wasan, K. M. (1999). Species Differences in the Proportion of Plasma Lipoprotein Lipid Carried by High-Density Lipoproteins Influence the Distribution of Free and Liposomal Nystatin in Human, Dog, and Rat Plasma. Antimicrob. Agents Chemother. 43: 1424-1428 [Abstract] [Full Text]  
  • Cassidy, S. M., Strobel, F. W., Wasan, K. M. (1998). Plasma Lipoprotein Distribution of Liposomal Nystatin Is Influenced by Protein Content of High-Density Lipoproteins. Antimicrob. Agents Chemother. 42: 1878-1888 [Abstract] [Full Text]  
  • Wasan, K. M., Ramaswamy, M., Ng, S. P., Wong, W., Parrott, S. C., Ojwang, J. O., Wallace, T., Cossum, P. A. (1998). Differences in the Lipoprotein Distribution of Free and Liposome-Associated All-trans-Retinoic Acid in Human, Dog, and Rat Plasma Are Due to Variations in Lipoprotein Lipid and Protein Content. Antimicrob. Agents Chemother. 42: 1646-1653 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»